[Changes in the system of antioxidant blood defence in newborns with different pathology]

L A Litvinenko1, L A Danilova, N P Shabalov

  • 1Saint-Petersburg Pediatric Medical Academy, Russia, 194100, Saint-Petersburg, Lytovskaya 2.

Voprosy Meditsinskoi Khimii
|December 25, 2002
PubMed

Insights

Newborn antioxidant enzyme activity varies with gestational age and health conditions like hypoxia and hemolytic disease. Haemosorption is a more effective treatment than blood transfusion for maintaining antioxidant levels.

Area of Science:

  • Biochemistry
  • Neonatal Physiology

Background:

  • Blood antioxidant enzymes, including superoxide dismutase (SOD), catalase, and ceruloplasmin, play crucial roles in protecting against oxidative stress.
  • Imbalances in these enzymes are implicated in various neonatal conditions, affecting infant health and survival.

Purpose of the Study:

  • To investigate the activity of blood antioxidant enzymes in newborns across different gestational ages and disease states.
  • To compare the efficacy of haemosorption versus exchange blood transfusion in managing antioxidant levels in newborns.

Main Methods:

  • Measurement of superoxide dismutase, catalase, and ceruloplasmin activity in blood samples from newborns.
  • Analysis of enzyme activity in relation to gestational age, hypoxia, and hemolytic disease.
  • Comparative assessment of antioxidant activity following haemosorption and exchange blood transfusion.

Main Results:

  • Significantly lower activity of superoxide dismutase and catalase was observed in premature infants and those experiencing acute or chronic hypoxia.
  • Newborns with hemolytic disease exhibited markedly higher antioxidant enzyme activity compared to healthy infants.
  • Haemosorption maintained high antioxidant activity, whereas blood transfusion led to decreased levels.

Conclusions:

  • Deficiency in antioxidant enzymes in newborns can result in toxic oxygen effects, highlighting their importance in neonatal health.
  • Antioxidants demonstrate potential as therapeutic agents for conditions characterized by oxidative stress in newborns.
  • Haemosorption presents an advantageous alternative to exchange blood transfusion for preserving blood antioxidant activity.

Related Concept Videos

Blood Types02:20

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...